In this ISSUE

Consider an Enterprise Wide Project Management Office

The Promise of Liquid Biopsy

Can we Learn to Do Less, but Still Do it Right?

Trial Management

Perspectives on Past, Present, and Future of Clinical Trials

As we mark a milestone year for our publication, several guest contributors look at the complexity issues in drug development still to overcome.
... /Read more/

A New Paradigm: Cutting-edge Processes and Analytics in Site and Patient Selection
Live Webinar: Thursday, July 20 at 11:00am EDT

Good Clinical Practices

How Pfizer Identifies and Tackles Clinical Trial Quality Events

We interviewed Pfizer exec, Dr. Jonathan Rowe, about how they are leveraging predictive models to manage study risk and quality.
... /Read more/

Capturing Continuous Glucose Monitoring Advantages
Live Webinar: Wednesday, June 28 at 11:00am EDT

Personalized Medicine

How to Pick the Right Drug Doses for Pregnant Women

The majority of pregnant women are prescribed treatments that can include antibiotics, antivirals and more. However, little to no information is available about the appropriate dose to prescribe or the potential adverse fetal effects.
... /Read more/

Selecting and Auditing a Technology Vendor for Biopharmaceutical Development
On Demand

Learn more

Clinical Trial Materials

IRT Bridges Clinical and Supply Together—and Why It Matters

4G Clinical head of marketing, Amy Ripston interviews Catherine Hall, director of operational excellence, at Sunovion to discuss how IRT bridges the gap between clinical and supply, and how interactive response technologies (IRT) can be leveraged to enable innovative trial designs.
... /Read more/

Achieve Better Outcomes with New RBM Tech Enhancements
On Demand

Learn more

Investigative Sites

Taking Stock of Today's Global Site Landscape

The nascent and fragmented global community of investigators is showing signs of scaling and maturing.
... /Read more/

Calendar

/ 6^th Annual Publication and Clinical Trial Transparency 6/27-6/28 /

/ Transformative Trial Models & Engagement 8/22-8/23 /

/ Global Risk-Based Monitoring 9/14-9/15 /

/ Interactive Response Technologies in Clinical Trials 2017 10/26-10/27 /

Minimal Residual Disease Detection: Key Considerations for Clinical Development in Oncology
Live Webcast: Thursday, June 29 at 11:00am EDT

Shortening Biosimilar Development: A Case Study Integrating Early Clinical (Phase I) with late phase (Phase III) Biosimilars Development
On Demand

Learn more

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Coming to terms with Patient Centricity
On Demand

Learn more

Advertise

Mike Tessalone
Publisher
Michael.Tessalone@ubm.com

Emerging Biopharma and Rare Disease: Finding a Needle in a Haystack
Data-driven Patient Recruitment Solutions
On Demand

Learn more

Talking the Patients' Language – the importance of effective, patient-centered engagement
On Demand

Learn more

website / blog / advertise / subscribe